Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.

Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.4.2 deployed, replacing the previous v3.4.1. This update appears to be a version bump with no changes to clinical trial details.SummaryDifference0.0%

- Check22 days agoChange DetectedThe revision label on the page changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision: v3.4.1 is displayed, replacing Revision: v3.4.0.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page includes minor UI and metadata updates: a 'Show glossary' option has been added; the 'Last Update Submitted' QC criteria label is now 'Last Update Submitted that Met QC Criteria'; capitalization for 'No FEAR Act Data' has been adjusted; and the revision version has been updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous v3.3.3. This appears to be a minor system update with no changes to study information.SummaryDifference0.0%

- Check73 days agoChange DetectedThe study locations were updated, with many new sites added across multiple countries and numerous previously listed locations removed.SummaryDifference3%

Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.